» Articles » PMID: 27727075

Chronic Obstructive Pulmonary Disease is Associated with Increased Recurrent Peptic Ulcer Bleeding Risk

Overview
Specialty General Medicine
Date 2016 Oct 12
PMID 27727075
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The association between chronic obstructive pulmonary disease (COPD) and the risk of recurrent peptic ulcer bleeding (PUB) remains unclear. In this study, we compared the risk of recurrent PUB between patients with and those without COPD.

Methods: Using the Taiwan National Health Insurance Research Database, we first selected patients newly diagnosed with PUB in 2002-2009. Two groups comprising 13,732 COPD cases and 13,732 non-COPD matched controls were created using propensity score matching, thereby making the differences in basic demographics, medication use, and disease conditions between the two groups negligible. Cox proportional hazard regression was used to evaluate the risk of recurrent PUB during the follow-up period.

Results: The cumulative recurrence rate of PUB was significantly higher in the patients with COPD than in the non-COPD matched controls (2years: 10.8% vs 9.3%; 6years: 18.3% vs 15.7%, P all <0.05), with an adjusted hazard ratio (HR) of 1.17 (95% confidence interval [CI], 1.08-1.26, P<0.001) and 1.19 (95% CI, 1.12-1.26, P<0.001) within 2-year and 6-year follow-ups, respectively. Patients with COPD using steroids were at a marginally higher risk of recurrent PUB than those who did not use steroids. Multivariate stratified analysis revealed similar results in many subgroups.

Conclusions: The risk of recurrent PUB is higher in patients with COPD than in patients without COPD.

Citing Articles

Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure.

Amin A, Kartashov A, Ngai W, Steele K, Rosenthal N J Health Econ Outcomes Res. 2024; 11(1):44-56.

PMID: 38390025 PMC: 10883471. DOI: 10.36469/001c.92408.


Common gastrointestinal diseases and chronic obstructive pulmonary disease risk: a bidirectional Mendelian randomization analysis.

Shen Z, Qiu B, Chen L, Zhang Y Front Genet. 2023; 14:1256833.

PMID: 38046045 PMC: 10690629. DOI: 10.3389/fgene.2023.1256833.


Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Buhr R, Jackson N, Dubinett S, Kominski G, Mangione C, Ong M J Hosp Med. 2020; 15(4):219-227.

PMID: 32118572 PMC: 7153488. DOI: 10.12788/jhm.3367.


Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms.

Avdeev S, Aisanov Z, Arkhipov V, Belevskiy A, Leshchenko I, Ovcharenko S Int J Chron Obstruct Pulmon Dis. 2019; 14:1267-1280.

PMID: 31354256 PMC: 6572750. DOI: 10.2147/COPD.S207775.


A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population.

Rodriguez-Manero M, Lopez-Pardo E, Cordero A, Ruano-Ravina A, Novo-Platas J, Pereira-Vazquez M Int J Chron Obstruct Pulmon Dis. 2019; 14:371-380.

PMID: 30863038 PMC: 6388772. DOI: 10.2147/COPD.S174443.